GlaxoSmithKline Pakistan Limited has announced a Board of Directors meeting scheduled for October 29, 2026, to review the financial results for the quarter ending September 30, 2026.
- Meeting Date: October 29, 2026
- Time: 12:00 PM (noon)
- Agenda: Consideration of financial results for Q3 2026
- Closed Period: October 22, 2026, to October 29, 2026 (inclusive)
- No trading by executives during the closed period